Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immunogenicity
100%
Human Metapneumovirus (hMPV)
100%
Receptor Binding
100%
Post-fusion
100%
F Protein
100%
Heparan Sulfate
13%
Genotype B
13%
Th1-Th2
9%
Vaccine Development
9%
Neutralizing Antibodies
9%
Monoclonal Antibody
9%
Fusion (F) Protein
9%
Antigenic Site
9%
Heparin Sulfate
9%
Immunization
4%
Vaccine Candidate
4%
Balb C Mice
4%
Genotype
4%
Th2 Response
4%
Viral Respiratory Infections
4%
Epitope
4%
X-ray Structure
4%
Structural Information
4%
Structural Difference
4%
Competition Analysis
4%
X-ray Crystal Structure
4%
Therapy Development
4%
Type 2 Immune Response
4%
Genotype A
4%
New Characteristics
4%
Trimeric
4%
Receptor-binding Properties
4%
Heparan Sulfate Binding Site
4%
Protective Efficacy
4%
Acute Respiratory Viral Infections
4%
Drug Antibodies
4%
Neutralizing Epitope
4%
Vaccine Target
4%
Heparin Binding
4%
Antibody Competition
4%
Binding Activity
4%
Response to Vaccination
4%
Immunology and Microbiology
Immunogenicity
100%
Human metapneumovirus
100%
Receptor Binding
100%
Conformation
100%
Epitope
9%
X Ray
9%
Neutralizing Antibody
9%
Monoclonal Antibody
9%
Crystal Structure
9%
Immune Response
4%
Bagg Albino Mouse
4%
Binding Affinity
4%
Drug Antibody
4%
Infection
4%